Compared with high NR1H3 expression, low expression of NR1H3 indicated a worse survival prognosis of OS (p = 0.047), RFS (p = 3e-04) and PPS (p = 0.033) in HER2-positive breast cancer (Figure 2H; Supplementary Figure S2H). This evidence concerns the gene ERBB2 and breast carcinoma.